Atomo NewsGet the app

Get the latest Science News and Discoveries

Pioneering CRISPR Gene Editing Trial: 79% of Participants See Improvement


CRISPR gene editing shows potential in treating blindness, with 79% of trial participants experiencing improved vision. About 79% of clinical trial participants experienced measurable improvement after receiving experimental, CRISPR-based gene editing that is designed to fix a rare form of blindn

None

Get the Android app

Or read this on SciTech Daily

Read more on:

Photo of participants

participants

Photo of Trial

Trial

Photo of improvement

improvement

Related news:

News photo

Microarray patches safe and effective for vaccinating children, trial suggests

News photo

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial

News photo

For the first time, researchers successfully used functional precision medicine — drug screening of hundreds of FDA approved drugs on patient tumor samples — to find treatments for children with relapsed cancers. This unique approach led to 83% of patients showing improvement.

« Hubble Snaps Striking New Photo of UGC 9684
Puppy-dog eyes in wild canines sparks rethink on dog evolution »